Holen Sie sich die Stockscreener-App
0.00
100.00%
-29.08
Handel nachbörslich:
29.30
29.30
+
Mersana Therapeutics Inc Aktie (MRSN) Neueste Nachrichten
Does Mersana Therapeutics Inc have pricing power2026 Support & Resistance & Technical Pattern Based Signals - baoquankhu1.vn
Day One Biopharmaceuticals Acquires Mersana Therapeutics: Key Financial Details, Purchase Price, and Pro Forma Impact - Minichart
Setup Watch: How is Mersana Therapeutics Inc. managing supply chain issues2026 Opening Moves & Daily Profit Focused Stock Screening - baoquankhu1.vn
Can Mersana Therapeutics Inc. (0M4) stock double in coming years2026 Big Picture & Detailed Earnings Play Strategies - Naître et grandir
Is Mersana Therapeutics Inc. stock a smart buy before Fed meetingGap Up & Low Risk Investment Opportunities - Naître et grandir
Aug Patterns: Is Mersana Therapeutics Inc a top pick in the sectorJuly 2025 Decliners & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Guidance Update: Does Mersana Therapeutics Inc have pricing powerWeekly Trend Summary & AI Enhanced Trading Signals - baoquankhu1.vn
MRSN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Day One Weighs OJEMDA Momentum Against Expanded Oncology Pipeline Risks - Sahm
Day One Biopharmaceuticals: Commercial Performance With Catalysts Ahead (NASDAQ:DAWN) - Seeking Alpha
Day One Highlights Transformational 2025 and OJEMDA Growth - TipRanks
Cancer drug OJEMDA powers Day One’s $155M year, bigger 2026 sales target set - Stock Titan
Day One Biopharmaceuticals earnings up next after Mersana deal - Investing.com Australia
Day One Biopharmaceuticals earnings up next after Mersana deal By Investing.com - Investing.com Canada
Market Outlook: Is Mersana Therapeutics Inc benefiting from interest rate changesJuly 2025 Drop Watch & Accurate Buy Signal Notifications - baoquankhu1.vn
How Mersana Therapeutics Inc. stock performs in weak economyJuly 2025 Setups & Daily Profit Focused Screening - mfd.ru
Resistance Check: How is Mersana Therapeutics Inc managing supply chain issuesTrade Analysis Report & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Growth Report: Can Mersana Therapeutics Inc. stock sustain revenue growth2025 Fundamental Recap & AI Forecasted Entry and Exit Points - mfd.ru
Published on: 2026-02-14 07:10:10 - mfd.ru
Is Mersana Therapeutics Inc. forming a bullish divergenceMarket Trend Review & Fast Gaining Stock Strategy Reports - mfd.ru
Can Mersana Therapeutics Inc. withstand a market correctionEarnings Growth Summary & Weekly High Conviction Trade Ideas - mfd.ru
Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026 - GlobeNewswire
Day One Biopharma to review Q4 and 2025 results in Feb. 24 webcast - Stock Titan
Is Mersana Therapeutics Inc a top pick in the sectorJuly 2025 Highlights & Verified Momentum Watchlists - baoquankhu1.vn
Aug Sentiment: What are Mersana Therapeutics Incs recent SEC filings showing2025 Market WrapUp & Precise Swing Trade Alerts - baoquankhu1.vn
Gap Down: Is Rockwell Automation Inc stock good for income investorsJuly 2025 Institutional & Breakout Confirmation Trade Signals - baoquankhu1.vn
Weekly Trades: What is the next catalyst for The Marygold Companies Inc2025 Earnings Surprises & Daily Stock Momentum Reports - baoquankhu1.vn
Income Plays: How analysts rate Mersana Therapeutics Inc stock today2025 Geopolitical Influence & Fast Momentum Entry Tips - Bộ Nội Vụ
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Sees Large Drop in Short Interest - MarketBeat
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance - The Manila Times
Day One Biopharmaceuticals Reports 172% Year-over-Year Growth in 2025 Net Product Revenue, Projects 2026 Revenue Between $225 Million and $250 Million - Quiver Quantitative
Cancer drug OJEMDA sales jump 172% in 2025 as Day One sets 2026 target - Stock Titan
Is Mersana Therapeutics Inc. stock positioned for long term growthJuly 2025 Action & AI Forecast for Swing Trade Picks - Улправда
Day One Biopharmaceuticals Stock Pre-Market (+5.4%) : Market Digests Mersana Acquisition - Trefis
Mersana Therapeutics (NASDAQ:MRSN) Upgraded at Wall Street Zen - MarketBeat
Is Mersana Therapeutics Inc. stock a buy on dipsWeekly Profit Report & Risk Controlled Swing Alerts - Улправда
Will Mersana Therapeutics Inc. stock maintain growth storyWeekly Trade Report & Fast Gain Stock Tips - Улправда
Published on: 2026-01-09 13:08:50 - Улправда
Is Mersana Therapeutics Inc. stock a buy before product launches2025 Technical Overview & AI Powered Trade Plan Recommendations - Улправда
Free cash flow of Mersana Therapeutics, Inc. – LSX:A41BV2 - TradingView — Track All Markets
How The Day One Deal Is Reshaping The Story For Mersana Therapeutics (MRSN) - Yahoo Finance
Day One concludes Mersana Therapeutics acquisition - Yahoo Finance
Mersana Therapeutics, Inc.Common Stock (NQ: MRSN - FinancialContent
Mersana Therapeutics Completes Merger and Delists from Nasdaq - The Globe and Mail
Day One Biopharmaceuticals completes acquisition of Mersana Therapeutics By Investing.com - Investing.com Nigeria
Day One Biopharmaceuticals completes acquisition of Mersana Therapeutics - Investing.com
Day One Biopharmaceuticals Completes Acquisition of Mersana Therapeutics - TipRanks
Mersana Therapeutics Announces Board and Management Changes Following Merger - TradingView — Track All Markets
Day One Biopharmaceuticals Completes Acquisition of Mersana Therapeutics to Enhance Oncology Pipeline - Quiver Quantitative
Day One Completes Acquisition of Mersana Therapeutics - The Manila Times
Day One buys Mersana to advance drug for rare salivary cancer - Stock Titan
Mersana Therapeutics, Inc.(NasdaqGS: MRSN) dropped from S&P TMI Index - marketscreener.com
PRN_FinancialWrapper | PR NewswireMersana Therapeutics, Inc.Common Stock (Nasdaq:MRSN) Price Chart - FinancialContent
Los Angeles Daily NewsMersana Therapeutics, Inc.Common Stock (Nasdaq:MRSN) Price Chart - FinancialContent
Panic Selling: Is Mersana Therapeutics Inc stock positioned for long term growthWeekly Risk Report & AI Driven Stock Reports - moha.gov.vn
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):